A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism

BACKGROUND: Male hypogonadism (testosterone level < 300 ng/dl) is a clinical syndrome that results from failure of the testis to produce physiological levels of testosterone. Most marketed testosterone replacement therapy products often require multiple dose adjustment clinic visits to achieve th...

Descripción completa

Detalles Bibliográficos
Autores principales: DelConte, Anthony, Papangkorn, Kongnara, Kim, Kilyoung, Bruno, Benjamin J., Chidambaram, Nachiappan, Khera, Mohit, Goldstein, Irwin, Kohler, Tobias S., Miner, Martin, Dobs, Adrian S., Patel, Mahesh V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304136/
https://www.ncbi.nlm.nih.gov/pubmed/34994093
http://dx.doi.org/10.1111/andr.13153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304136/
https://www.ncbi.nlm.nih.gov/pubmed/34994093
http://dx.doi.org/10.1111/andr.13153

Ejemplares similares